NO20021730L - Ny formulering av mirtazapin - Google Patents

Ny formulering av mirtazapin

Info

Publication number
NO20021730L
NO20021730L NO20021730A NO20021730A NO20021730L NO 20021730 L NO20021730 L NO 20021730L NO 20021730 A NO20021730 A NO 20021730A NO 20021730 A NO20021730 A NO 20021730A NO 20021730 L NO20021730 L NO 20021730L
Authority
NO
Norway
Prior art keywords
mirtazapine
new formulation
formulation
new
Prior art date
Application number
NO20021730A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021730D0 (no
Inventor
Henrik De Nijs
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240737&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20021730(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20021730D0 publication Critical patent/NO20021730D0/no
Publication of NO20021730L publication Critical patent/NO20021730L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20021730A 1999-10-13 2002-04-12 Ny formulering av mirtazapin NO20021730L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99203338 1999-10-13
PCT/EP2000/009863 WO2001026621A2 (en) 1999-10-13 2000-10-09 Orally distintegrating composition comprising mirtazapine

Publications (2)

Publication Number Publication Date
NO20021730D0 NO20021730D0 (no) 2002-04-12
NO20021730L true NO20021730L (no) 2002-05-30

Family

ID=8240737

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021730A NO20021730L (no) 1999-10-13 2002-04-12 Ny formulering av mirtazapin

Country Status (28)

Country Link
EP (1) EP1223914B1 (sk)
JP (1) JP5561885B2 (sk)
KR (1) KR100708560B1 (sk)
CN (1) CN1173701C (sk)
AR (1) AR026010A1 (sk)
AT (1) ATE274899T1 (sk)
AU (1) AU780379B2 (sk)
BR (1) BR0014593A (sk)
CA (1) CA2386547C (sk)
CO (1) CO5251412A1 (sk)
CZ (1) CZ20021315A3 (sk)
DE (2) DE1223914T1 (sk)
ES (1) ES2194618T3 (sk)
HK (1) HK1046641B (sk)
HU (1) HUP0203148A3 (sk)
IL (2) IL148777A0 (sk)
MX (1) MXPA02003519A (sk)
NO (1) NO20021730L (sk)
NZ (1) NZ518165A (sk)
PE (1) PE20010699A1 (sk)
PL (1) PL200858B1 (sk)
PT (1) PT1223914E (sk)
RU (1) RU2261098C2 (sk)
SK (1) SK6452002A3 (sk)
TR (1) TR200200978T2 (sk)
TW (1) TWI256309B (sk)
WO (1) WO2001026621A2 (sk)
ZA (1) ZA200202293B (sk)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005051349A2 (en) * 2003-11-25 2005-06-09 Aurobindo Pharma Ltd. Pharmaceutical compositions of mirtazapine
DE102004034043A1 (de) * 2004-07-13 2006-02-09 Krka Tovarna Zdravil, D.D. Feste pharmazeutische Zusammensetzung, die Mirtazapin enthält
JP2009528289A (ja) * 2006-02-27 2009-08-06 ミシャロウ、アレクサンダー 対抗適応を誘発することにより神経伝達物質系を調節する方法
CN101129341B (zh) * 2006-08-22 2011-06-01 上海医药工业研究院 口内崩解组合物及其制备方法
EP2377522B1 (en) 2010-04-15 2013-01-16 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
CN102993208B (zh) * 2011-11-22 2017-01-18 北京哈三联科技股份有限公司 去甲肾上腺素和选择性五羟色胺受体阻断剂及其应用
NZ629468A (en) * 2012-03-02 2017-08-25 Rhodes Pharmaceuticals Lp Tamper resistant immediate release formulations
CN104095824B (zh) * 2013-04-09 2016-08-31 上海信谊万象药业股份有限公司 一种米氮平缓释片及其制备方法
RS62055B1 (sr) 2015-02-27 2021-07-30 Dechra Ltd Stimulacija apetita, upravljanje gubitkom težine i lečenje anoreksije kod pasa i mačaka
JP6601844B2 (ja) * 2016-12-05 2019-11-06 共和薬品工業株式会社 光安定性に優れたミルタザピン含有医薬製剤
CN111714463B (zh) * 2020-08-14 2022-06-17 华农（肇庆）生物产业技术研究院有限公司 米氮平口服剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
DE69029273T2 (de) * 1989-10-02 1997-06-12 Cima Labs Inc Brausedosisform sowie verfahren zu deren verabreichung
IE63986B1 (en) * 1989-12-30 1995-06-28 Akzo Nv Pharmaceutical preparation for oral administration in fluid form
JPH0436252A (ja) * 1990-05-30 1992-02-06 Nippon Alkyl Alum Kk 光学活性アルキニルアルコールの製造方法
JP3168695B2 (ja) * 1991-06-14 2001-05-21 三菱化学株式会社 ショ糖脂肪酸エステルの置換度の低下方法
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
JPH05163137A (ja) * 1991-12-12 1993-06-29 Shin Etsu Chem Co Ltd 有核顆粒
JPH0737473A (ja) * 1993-07-27 1995-02-07 Murata Mfg Co Ltd 圧力スイッチ
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
JPH10139659A (ja) * 1996-09-10 1998-05-26 Freunt Ind Co Ltd 球形粒子群、その製造方法及びそれを用いた球形粒子製剤
JP3870470B2 (ja) * 1997-02-07 2007-01-17 大正製薬株式会社 マルチプルユニットタイプ徐放性錠剤

Also Published As

Publication number Publication date
AU1023201A (en) 2001-04-23
WO2001026621A3 (en) 2001-10-11
DE60013466D1 (de) 2004-10-07
HK1046641A1 (en) 2003-01-24
CA2386547C (en) 2010-06-08
CN1378452A (zh) 2002-11-06
DE1223914T1 (de) 2003-09-18
KR100708560B1 (ko) 2007-04-19
PE20010699A1 (es) 2001-07-06
SK6452002A3 (en) 2002-09-10
PT1223914E (pt) 2004-11-30
IL148777A (en) 2013-10-31
HK1046641B (zh) 2005-04-08
KR20020038946A (ko) 2002-05-24
CA2386547A1 (en) 2001-04-19
HUP0203148A2 (hu) 2003-01-28
CZ20021315A3 (cs) 2002-07-17
NZ518165A (en) 2004-03-26
BR0014593A (pt) 2002-06-11
AR026010A1 (es) 2002-12-26
NO20021730D0 (no) 2002-04-12
TWI256309B (en) 2006-06-11
PL200858B1 (pl) 2009-02-27
ZA200202293B (en) 2003-06-20
JP2003511403A (ja) 2003-03-25
HUP0203148A3 (en) 2004-06-28
RU2261098C2 (ru) 2005-09-27
ATE274899T1 (de) 2004-09-15
AU780379B2 (en) 2005-03-17
IL148777A0 (en) 2002-09-12
CN1173701C (zh) 2004-11-03
PL354584A1 (en) 2004-01-26
JP5561885B2 (ja) 2014-07-30
ES2194618T3 (es) 2005-04-01
DE60013466T2 (de) 2005-01-20
WO2001026621A2 (en) 2001-04-19
MXPA02003519A (es) 2002-08-20
EP1223914B1 (en) 2004-09-01
EP1223914A2 (en) 2002-07-24
ES2194618T1 (es) 2003-12-01
CO5251412A1 (es) 2003-02-28
RU2002112238A (ru) 2004-01-10
TR200200978T2 (tr) 2002-09-23

Similar Documents

Publication Publication Date Title
NO995852D0 (no) Ny form av S-omeprazol
NO20022979L (no) Anvendelse av organiske forbindelser
AR028567A1 (es) Nuevos derivados de fenil-propargileter
NO20015855L (no) Ny anvendelse av forbindelser som antibakterielle midler
DK1261585T3 (da) Substituerede indol-Mannichbaser
AR028596A1 (es) Nuevos derivados de fenilglicina
ID30233A (id) Antibiotika ketolida
NO20020185D0 (no) Formuleringer av IL-11
DE60019960D1 (de) Herstellung von isobutencopolymere
FI19992855A (fi) Valaisuolosuhteiden mittaus
NO20021860L (no) Formulering av substituerte benzimidazoler
NO20021730L (no) Ny formulering av mirtazapin
NO20041968L (no) Anvendelse av cystationin
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
NO20023785L (no) Vanndispergerbar formulering av paroxetin
LU90483B1 (fr) Compositions nouvelles de m-thanesulfonate de parox-tine
DE60016608D1 (de) Herstellung von sulfonylimin-verbindungen
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
NO20004816D0 (no) Ny farmasøytisk formulering
NO20033163D0 (no) Ny anvendelse av iloperidon
NO20016030L (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
NO20022446D0 (no) Etere av O-desmetyl-venlafaxine
NO20021234D0 (no) Anvendelse av tienopyrimidiner
NO20005856D0 (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application